Page 41 - MEMENTO THERAPEUTIQUE RCP 2024
P. 41

1.    NAME OF THE MEDICINAL PRODUCT

               Elymbus 0.1 mg/g eye gel in single-dose container


               2.    QUALITATIVE AND QUANTITATIVE COMPOSITION

               One g of eye gel contains 0.1 mg bimatoprost.

               For the full list of excipients, see section 6.1.


               3.    PHARMACEUTICAL FORM

               Eye gel.
               Colourless opalescent gel.
               pH: 6.9 – 7.9.
               Osmolality: 250 – 350 mosmol/kg.


               4.    CLINICAL PARTICULARS

               4.1   Therapeutic indications

               Reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension in
               adults (as monotherapy or as adjunctive therapy to beta-blockers).

               4.2   Posology and method of administration

               Posology
               The recommended dose is one drop in the affected eye(s) once daily, administered in the evening. The
               dose should not exceed once daily, as more frequent administration may lessen the intraocular pressure
               lowering effect.

               Special populations
               Patients with hepatic impairment
               Elymbus has not been  studied  in patients with moderate to severe  hepatic impairment and should
               therefore be used with caution in such patients. In  patients with  a history of  mild  liver disease or
               abnormal alanine aminotransferase (ALT), aspartate aminotransferase (AST) and/or bilirubin at
               baseline, bimatoprost 0.3 mg/ml eye drops, solution (preserved formulation) had no adverse effect on
               liver function over 24 months.

               Patients with renal impairment
               Elymbus has not been studied in patients with renal impairment and should therefore be used with
               caution in such patients.

               Paediatric population
               The safety and efficacy of Elymbus in children aged 0 to 18 years has not yet been established.

               Method of administration
               Ocular use.
               The use of bimatoprost in contact lens wearers has not been studied. Therefore, contact lenses should
               be removed before instillation of the eye gel and may be reinserted after 15 minutes.
               If more than one topical ophthalmic medicinal product is being used, they should be administered at
               least 15 minutes before Elymbus. Elymbus should be instilled last.
               A single-dose container contains enough eye gel to treat both eyes.


                                                            2
   36   37   38   39   40   41   42   43   44   45   46